Ocular Hypertension: all 659 studies
Page 3 of 7. Open to participants first (48), then studies with results posted, then the rest; newest registration first within each.
- Long-Term Safety of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular HypertensionCompletedNCT01298700Phase 4Results posted
- Three Month Efficacy/Safety Study With a 3-Month Safety Extension of Brinzolamide 1%/Brimonidine 0.2% vs. Brinzolamide 1% or Brimonidine 0.2%CompletedNCT01297920Phase 3Results posted
- Efficacy and Safety Study of Brinzolamide 1%/Brimonidine 0.2% vs. Brinzolamide 1% and Brimonidine 0.2%CompletedNCT01297517Phase 3Results posted
- Safety and Efficacy of AGN-210669 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT01291108Phase 2Results posted
- 24-hour IOP-lowering Effect of 0.01% BimatoprostCompletedNCT01271686Phase 4Results posted
- Long-Term Non-Interventional Latanoprost StudyCompletedNCT01265719Results posted
- Safety and Efficacy of Adding AZARGA® Adjunctive to Prostaglandin TherapyCompletedNCT01263444Phase 4Results posted
- Preservative-Free Tafluprost (MK-2452) for the Treatment of Open-Angle Glaucoma or Ocular Hypertension (MK-2452-002)CompletedNCT01254604Phase 3Results posted
- Ocular Surface Tolerability Study of Prostaglandin Analogues in Patients With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT01253902Phase 4Results posted
- Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular HypertensionCompletedNCT01241240Phase 3Results posted
- Safety and Efficacy of Brimonidine Tartrate/Timolol Fixed Combination in Patients With Glaucoma or Ocular HypertensionCompletedNCT01229462Not applicableResults posted
- Study Comparing the Safety and Efficacy of BOL-303259-X to Latanoprost in Subjects With Glaucoma or Ocular HypertensionCompletedNCT01223378Phase 2Results posted
- Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular HypertensionCompletedNCT01217606Phase 3Results posted
- Safety and Efficacy of Triple Combination Therapy in Patients With Glaucoma or Ocular HypertensionCompletedNCT01216943Phase 3Results posted
- Safety and Pharmacodynamics Study of AGN-207281 Ophthalmic Solutions Compared With Timolol Ophthalmic Solution or Placebo in Patients With Ocular Hypertension or Primary Open-Angle GlaucomaCompletedNCT01215786Phase 1Results posted
- Long Term Use Of Xalacom In Patients Glaucoma Or Ocular HypertensionCompletedNCT01191008Results posted
- Safety and Efficacy of a New Formulation of Bimatoprost/Timolol Ophthalmic Solution Compared With Bimatoprost/Timolol Ophthalmic Solution in Patients With Glaucoma or Ocular HypertensionCompletedNCT01177098Phase 3Results posted
- A Phase IIa Study to Assess the Tolerability, Safety, and Efficacy of AZD4017 for Raised Intra-ocular PressureCompletedNCT01173471Phase 2Results posted
- Comparing Safety and Efficacy of Combigan® and Lumigan® With Lumigan® Alone in Glaucoma or Ocular Hypertension Subjects Treated With Xalatan®CompletedNCT01170884Phase 4Results posted
- Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular HypertensionCompletedNCT01157364Phase 1/2Results posted
- Travoprost Five Day Posology StudyCompletedNCT01114893Phase 2Results posted
- Safety and Efficacy of AGN-210961 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular HypertensionCompletedNCT01110499Phase 2Results posted
- Safety and Efficacy of Different Formulations of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular HypertensionCompletedNCT01099774Phase 3Results posted
- Safety and Efficacy of Bimatoprost Timolol Ophthalmic Solution in Patients With Open Angle Glaucoma or Ocular HypertensionCompletedNCT01068964Not applicableResults posted
- Clinical Study of A Fixed Combination of Timolol-Brimonidine-DorzolamideCompletedNCT01062971Phase 2Results posted
- Safety and Efficacy of Daily CF101 Administered Orally in Subjects With Elevated Intraocular PressureCompletedNCT01033422Phase 2Results posted
- Preservative-Free MK2452 (Tafluprost) for Open-Angle Glaucoma/Ocular Hypertension (MK2452-001)(COMPLETED)CompletedNCT01026831Phase 3Results posted
- Safety and Efficacy of a Drug Delivery System in GlaucomaCompletedNCT01016691Phase 2Results posted
- Non-Interventional Study In Patients With Ocular Hypertension And Open Angle Glaucoma Treated With Xalatan And XalacomCompletedNCT01012245Results posted
- Safety and Efficacy of Three Formulations of AGN-210669 Ophthalmic Solution Compared With Bimatoprost Ophthalmic SolutionCompletedNCT01001195Phase 2Results posted
- Safety and Efficacy of Brinzolamide/Brimonidine Fixed CombinationTerminatedNCT00961649Phase 2Results posted
- Efficacy and Tolerability of Xalatan in PatientsCompletedNCT00950690Results posted
- Efficacy and Safety of SPARC0912 and Reference0912 in Open Angle Glaucoma or Ocular HypertensionCompletedNCT00947661Phase 3Results posted
- Evaluation of Safety of SPARC0913 in Open Angle Glaucoma or Ocular HypertensionCompletedNCT00945958Phase 3Results posted
- A Phase 2 Study Of The 24-Hour Intraocular Pressure Lowering And Systemic Exposure Of PF-04217329CompletedNCT00934089Phase 2Results posted
- Pharmacodynamics of Tafluprost 0.0015% Eye Drops: a Comparison Between the Preserved and Unpreserved FormulationCompletedNCT00918346Phase 3Results posted
- Efficacy Study of Travoprost APS Versus TRAVATANCompletedNCT00848536Phase 3Results posted
- A Retrospective Evaluation of the Intraocular Pressure Spikes With Loteprednol and Loteprednol/TobramycinCompletedNCT00834171Results posted
- Safety and Efficacy of a Glaucoma Drug Delivery SystemCompletedNCT00824720Phase 2Results posted
- A Comfort Survey of Open-angle Glaucoma or Ocular Hypertension Patients Treated With 2 DrugsCompletedNCT00823043Results posted
- An Evaluation of the Fixed Combination Brimonidine Tartrate 0.2%/ Timolol Maleate 0.5% to Latanoprost 0.005% in Glaucoma or Ocular Hypertension SubjectsCompletedNCT00811564Phase 4Results posted
- Safety and Efficacy of AGN 210669 Ophthalmic Solution in Patients With Ocular Hypertension or Primary Open-Angle GlaucomaCompletedNCT00809848Phase 1/2Results posted
- Patient Satisfaction With Timolol in Subjects With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00804648Phase 4Results posted
- Examination of Ocular Surface Effects With Administration of Travatan Z and XALATANCompletedNCT00798759Phase 4Results posted
- Travatan Versus Timoptic in Treating Open-angle Glaucoma or Ocular HypertensionCompletedNCT00763061Phase 4Results posted
- Phase III Clinical Trial of TRAVATAN Z in Ocular Surface HealthCompletedNCT00761319Phase 3Results posted
- Comparing Efficacy and Safety of Combigan With Timolol Adjunctive to Xalatan in Glaucoma or Ocular Hypertension SubjectsCompletedNCT00735449Phase 4Results posted
- Safety and Efficacy Study of Bimatoprost, Latanoprost, and Travoprost in Patients With Elevated Intraocular Pressure (IOP) and Open-angle Glaucoma (OAG)CompletedNCT00716742Results posted
- Effects of Travatan Z and Xalatan on Ocular Surface HealthCompletedNCT00708422Phase 4Results posted
- Travatan Z in Ocular Surface Health in Patients With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00690794Phase 3Results posted
- A Phase 2, Dose Finding Study of PF-03187207 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension.CompletedNCT00595101Phase 2Results posted
- Safety and Efficacy of PF-04217329 in Patients With Glaucoma or Elevated Eye Pressure.CompletedNCT00572455Phase 2Results posted
- Dry Eye Study With Cosopt® Over 8 Weeks in Patients With Open-Angle Glaucoma or Ocular Hypertension (0507A-152)(COMPLETED)CompletedNCT00545064Phase 4Results posted
- Safety and Efficacy of Bimatoprost Compared With Latanoprost in Patients With Glaucoma or Ocular HypertensionCompletedNCT00541242Phase 4Results posted
- Evaluation of Hyperemia With the Use of Ocular Prostaglandin AnaloguesCompletedNCT00539526Phase 4Results posted
- A Study of the Safety and Efficacy of Bimatoprost in Patients With Glaucoma or Ocular HypertensionCompletedNCT00538304Phase 2Results posted
- A Single Dose Comfort Comparison of Travatan Z in One Eye Versus Xalatan in the Opposite Eye in Patients With Primary Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00527592Phase 4Results posted
- Adherence Assessment With Travalert Dosing AidCompletedNCT00508469Phase 4Results posted
- Non Interventional Study in Patients With Open Angle Glaucoma and/or Ocular Hypertension Treated With XALATAN®CompletedNCT00486252Results posted
- A Phase IV Study of Travoprost + Brinzolamide to Treat Glaucoma or Ocular HypertensionCompletedNCT00471380Phase 4Results posted
- Study of Travatan and Cosopt in Primary Open-Angle Glaucoma or Ocular HypertensionTerminatedNCT00471068Phase 4Results posted
- 24-hour IOP-lowering Effect of Brimonidine 0.1%CompletedNCT00457795Phase 4Results posted
- MK0507A Clinical Study in Patients With Glaucoma and Ocular Hypertension (0507A-149)(COMPLETED)CompletedNCT00449956Phase 3Results posted
- Dose-Finding Study Comparing the Safety and Efficacy of Latanoprost to a Novel Treatment for GlaucomaCompletedNCT00441883Phase 2Results posted
- Bimatoprost 0.03% Versus Travoprost 0.004% in Patients Currently on Latanoprost 0.005%CompletedNCT00440011Phase 4Results posted
- A Study Comparing Xalacom And Xalatan In Patients With Primary Open Angle Glaucoma (POAG) Or Ocular Hypertension (OH).CompletedNCT00383019Phase 3Results posted
- A Long-term Safety Study of Once-daily TravatanCompletedNCT00051168Phase 3Results posted
- Ocular Hypertension Treatment Study (OHTS)CompletedNCT00000125Phase 3Results posted
- Artificial Intelligence for Staging Glaucoma Severity: A Comparison With an Eye Specialist Using Visual Field TestsCompletedNCT07820709
- Prevalence of Glaucoma and Normative Data of Ocular Biometry in Elderly Population in BangkokCompletedNCT07763288
- Clinical Investigation of Eye C Better's Photobionic Intraocular Pressure Biomonitor TonometerActive, not recruitingNCT07762053Not applicable
- Selective, Micropulse and Pattern Laser Trabeculoplasty in Medically Treated Open-angle Glaucoma.CompletedNCT07756411Not applicable
- Prophylactic Use of Timolol Maleate to Prevent Intraocular Pressure Elevation After Nd:YAG Laser Posterior CapsulotomyCompletedNCT07729189Not applicable
- Dorzolamide/Brimonidine/Timolol Impact on Ocular Surface, Glaucoma Progression & Chatbot Follow-up: GLAUCO-TECHActive, not recruitingNCT07690397Phase 4
- Effect of Infusion Warming on Mannitol Infusion Pain in Patients With Acute Ocular HypertensionCompletedNCT07495449Not applicable
- Study of QLS-111-FDC in Open-Angle Glaucoma or Ocular HypertensionCompletedNCT07354516Phase 2/3
- AI-Assisted Detection of Posterior Segment Diseases: DR, AMD, RVO, and GlaucomaCompletedNCT07318428Not applicable
- Observational Study to Evaluate Long Term Outcomes for Ocular Hypertension and Glaucoma Patients Treated With the SpyGlass Bimatoprost Implant System / IOL CombinationActive, not recruitingNCT07154810
- Evaluation of the Safety and Effectiveness of the Bimatoprost Implant System / IOL Combination in Patients With Ocular Hypertension or Mild to Moderate Open-angle GlaucomaCompletedNCT07154797Not applicable
- Reformulated PG324 Ophthalmic Solution for Intraocular Pressure ReductionCompletedNCT07082816Phase 3
- This Follow-up Extension Study is Aimed to Monitor the Long-term IOP-lowering Performance/Efficacy and Safety of the MINT® Procedure in Open Angle Glaucoma Eyes.CompletedNCT07081347Not applicable
- Evaluate Efficacy and Safety of PA5108 Ocular Implants in Primary Open Angle Glaucoma or Ocular HypertensionActive, not recruitingNCT06964191Phase 2
- Evaluate Efficacy, Safety, Tolerability and Biodegradation of PA5346 Ocular Implant in Patients With Open-Angle Glaucoma or Ocular HypertensionActive, not recruitingNCT06964061Phase 1
- Effect of Rhopressa on Intraocular Pressure (IOP) in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension Post-SLTActive, not recruitingNCT06865144Phase 4
- Transscleral Selective Laser Trabeculoplasty ProjectCompletedNCT06833060Not applicable
- Long-term Outcomes of Glaucoma Surgery in a Real-life Setting: the Agora Registry StudyCompletedNCT06829810
- An Observational Study to Evaluate the ETX-4143 Device in Subjects With Ocular HypertensionWithdrawnNCT06709300
- 24-hour Wear Performance and Safety Study of Smartlens miLens Contact Lens for IOP MonitoringCompletedNCT06689696
- A Phase III Study in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension in ChinaActive, not recruitingNCT06666855Phase 3
- A Real-World Evidence Study of Goniotomy With the C-REX™ Instrument in Patients With Primary Open Angle GlaucomaActive, not recruitingNCT06615661
- Open-Label Study of Safety of H1337 in Healthy VolunteersCompletedNCT06572397Phase 1
- CRISPR/Cas9 Instantaneous Gene Editing Therapy to Intraocular Hypertensive POAG With MYOC MutationSuspendedNCT06465537Not applicable
- Next Generation RocklatanCompletedNCT06441643Phase 2
- EVALUATION of CATS TONOMETER PRISM in LASIK SUBJECTSCompletedNCT06266351
- Qlaris Study of QLS-111 in Combination With a PGA for OAG and/or OHT PatientsCompletedNCT06249152Phase 2
- Evaluation of Performance and Safety of Carbopol 980 NF 0.2%- Based Medical Device in the Management of Patients With Glaucomar or Ocular Hypertension and Concomitant Dry Eye Syndrome on Multiple Long-term Topical Hypotensive TherapyTerminatedNCT06190028Not applicable
- Evaluation of the Bimatoprost Implant System Used in Combination With the SpyGlass Intraocular Lens Compared to Timolol Ophthalmic SolutionActive, not recruitingNCT06120842Phase 1/2
- Eye Health Intervention Study in Upper ManhattanWithdrawnNCT06112431Not applicable
- Travoprost Intraocular Implant in Conjunction With Cataract SurgeryActive, not recruitingNCT06061718Phase 3
- Qlaris Phase 2 Study of QLS-111 in POAG And/or OHT PatientsCompletedNCT06016972Phase 2